Impact of Bupivacaine Dilution With Dextrose or Saline on Infraclavicular Block Outcomes
Recruiting
N/A
Interventional Study
Infraclavicular Brachial Plexus Block
Dextrose
Bupivacaine
Block Success
Postoperative Analgesia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 90 (estimated)
- Sponsor
- Burçin Alaçam, MD · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
D5W) has long been used as an intravenous fluid for hydration and energy supplementation and has recently gained increasing clinical interest in perineural injection therapies and ultrasound-guided hydrodissection. D5W has been shown to improve pain and functional outcomes in entrapment neuropathies by mechanically releasing perineural adhesions and potentially modulating neurogenic inflammation. …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients who agree to participate in the study and provide written informed consent
* Patients scheduled for elective upper extremity surgery for whom infraclavicular block is considered appropriate for anesthetic management
* Age between 18 and 65 years
* American Society of …
Contacts